ATE520033T1 - Neurotoxische aminosäure oder neurotoxisches derivat davon in zusammenhang mit neurologischen erkrankungen - Google Patents

Neurotoxische aminosäure oder neurotoxisches derivat davon in zusammenhang mit neurologischen erkrankungen

Info

Publication number
ATE520033T1
ATE520033T1 AT07018126T AT07018126T ATE520033T1 AT E520033 T1 ATE520033 T1 AT E520033T1 AT 07018126 T AT07018126 T AT 07018126T AT 07018126 T AT07018126 T AT 07018126T AT E520033 T1 ATE520033 T1 AT E520033T1
Authority
AT
Austria
Prior art keywords
bmaa
derivative
neurotoxic
amino acid
environmental sample
Prior art date
Application number
AT07018126T
Other languages
English (en)
Inventor
Paul Alan Cox
Sandra Banack
Susan Murch
Original Assignee
Inst Ethnomedicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Ethnomedicine filed Critical Inst Ethnomedicine
Application granted granted Critical
Publication of ATE520033T1 publication Critical patent/ATE520033T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07018126T 2003-08-12 2003-12-08 Neurotoxische aminosäure oder neurotoxisches derivat davon in zusammenhang mit neurologischen erkrankungen ATE520033T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49468603P 2003-08-12 2003-08-12

Publications (1)

Publication Number Publication Date
ATE520033T1 true ATE520033T1 (de) 2011-08-15

Family

ID=34215892

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07018126T ATE520033T1 (de) 2003-08-12 2003-12-08 Neurotoxische aminosäure oder neurotoxisches derivat davon in zusammenhang mit neurologischen erkrankungen
AT03818362T ATE377758T1 (de) 2003-08-12 2003-12-08 Neurotoxische aminosäure oder neurotoxisches derivat davon im zusammenhang mit neurologischen störungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03818362T ATE377758T1 (de) 2003-08-12 2003-12-08 Neurotoxische aminosäure oder neurotoxisches derivat davon im zusammenhang mit neurologischen störungen

Country Status (11)

Country Link
US (5) US7256002B2 (de)
EP (2) EP1860441B1 (de)
JP (1) JP4312203B2 (de)
CN (1) CN100595588C (de)
AT (2) ATE520033T1 (de)
AU (1) AU2003296424A1 (de)
CA (1) CA2535663C (de)
DE (1) DE60317379T2 (de)
DK (1) DK1664793T3 (de)
HK (1) HK1090696A1 (de)
WO (1) WO2005019830A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003296424A1 (en) * 2003-08-12 2005-03-10 Institute For Ethnomedicine Neurotoxic amino acid or neurotoxic derivative thereof associated with neurological disorders
US7932287B2 (en) * 2004-08-12 2011-04-26 Chemgenes Corporation Therapeutic compositions and uses
EP2453237B1 (de) 2005-05-23 2016-12-21 Harald F. Hess Optische Mikroskopie mit phototransformierbaren optischen Markern
DE102006030976A1 (de) 2006-07-03 2008-01-17 Behrens, Meinhard, Dr. Verfahren zum qualitativen Nachweis von zugesetzten Eiweiß-Stoffen in Lebensmitteln
EP2313776B1 (de) * 2008-07-09 2013-10-30 The Institute for Ethnomedicine Immunassays zur erkennung von mit neurologischen erkrankungen assoziierter neurotoxischer aminosäure
CN102234240B (zh) * 2011-05-05 2014-04-09 江苏弘和药物研发有限公司 L-bmaa盐酸盐的合成方法
CA2855854C (en) 2011-11-21 2020-03-31 The Institute For Ethnomedicine L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
US8394596B1 (en) 2012-04-13 2013-03-12 Abraxis LLC Antibodies and assays for beta-N-methylamino-L-alanine
ITRM20130253A1 (it) * 2013-04-29 2014-10-30 Canox4Drug S P A Metodo per la determinazione del rame libero
CN103837620A (zh) * 2014-03-21 2014-06-04 上海硕源健标生物医学科技有限公司 一种同时检测人体血浆中多种氨基酸含量的方法
CN106053678A (zh) * 2016-08-16 2016-10-26 汤臣倍健股份有限公司 一种辅助降血糖片深加工产品中4‑羟基异亮氨酸含量的检测方法
CN107334651A (zh) * 2017-07-05 2017-11-10 芜湖凌梦电子商务有限公司 一种营养去屑洗发香波
CN107157790A (zh) * 2017-07-05 2017-09-15 芜湖凌梦电子商务有限公司 营养去屑洗发香波
CN107157793A (zh) * 2017-07-05 2017-09-15 芜湖凌梦电子商务有限公司 一种营养洗发香波
CN109524112A (zh) * 2018-12-26 2019-03-26 杭州电子科技大学 一种基于部分定向相干法的脑功能网络构建方法
CN113466469B (zh) * 2021-07-07 2024-01-16 北京常友生物科技有限公司 自闭症检测的生物标志物、检测试剂盒及检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210076A (en) * 1988-09-13 1993-05-11 Berliner David L Methods of treating Parkinson's disease using melanin
US5824554A (en) * 1994-09-09 1998-10-20 Mckay; Florine M. Detection of allergenic substances in food products
US6043283A (en) 1996-09-20 2000-03-28 Baylor College Of Medicine Tyramine compounds and their neuronal effects
EP1334368B1 (de) * 2000-11-03 2015-02-25 Neurodyn, Inc. Sterolglukosid-toxine
AU2003296424A1 (en) * 2003-08-12 2005-03-10 Institute For Ethnomedicine Neurotoxic amino acid or neurotoxic derivative thereof associated with neurological disorders

Also Published As

Publication number Publication date
CN1860369A (zh) 2006-11-08
EP1664793B1 (de) 2007-11-07
EP1860441B1 (de) 2011-08-10
US7670783B2 (en) 2010-03-02
US7256002B2 (en) 2007-08-14
HK1090696A1 (en) 2006-12-29
JP2007521464A (ja) 2007-08-02
CN100595588C (zh) 2010-03-24
ATE377758T1 (de) 2007-11-15
CA2535663A1 (en) 2005-03-03
EP1860441A2 (de) 2007-11-28
WO2005019830A1 (en) 2005-03-03
DK1664793T3 (da) 2008-01-28
EP1664793B9 (de) 2008-07-16
EP1664793A1 (de) 2006-06-07
US20070292893A1 (en) 2007-12-20
JP4312203B2 (ja) 2009-08-12
US20070254315A1 (en) 2007-11-01
US20110183424A1 (en) 2011-07-28
US7901895B2 (en) 2011-03-08
US8541184B2 (en) 2013-09-24
US10048278B2 (en) 2018-08-14
DE60317379D1 (de) 2007-12-20
CA2535663C (en) 2011-02-08
US20050042686A1 (en) 2005-02-24
DE60317379T2 (de) 2008-09-11
US20140080140A1 (en) 2014-03-20
EP1860441A3 (de) 2008-03-05
AU2003296424A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
HK1090696A1 (en) Neurotoxic amino acid or neurotoxic derivative thereof associated with neurological disorders
Cornachione et al. Characterization of fiber types in different muscles of the hindlimb in female weanling and adult Wistar rats
DE502005009914D1 (de) Bestimmung von felinem und caninem probnp
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
DE60041839D1 (de) Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs
PL1836500T3 (pl) Sposoby i testy do rozróżniania między różnymi postaciami chorób i zaburzeń cechujących się małopłytkowością i/lub samoistną interakcją między czynnikiem von Willebranda (vWF) a płytkami krwi
NO20052992D0 (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
PT2073008E (pt) Métodos de imunoensaio melhorados
EA200700552A1 (ru) Способ оценки нефтезаводского сырья
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
WO2006113245A3 (en) Methods for measuring glycan levels of proteins
DK2038430T3 (da) Toll-Like-Receptor-4-dysfunktion og de biologiske anvendelser deraf
DE602006014798D1 (de) Vorrichtung und Verfahren zur Unterscheidung zwischen akuter und chronischer Myokardial-Nekrose bei symptomatischen Patienten
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
ATE462140T1 (de) Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
WO2003042659A3 (en) Rapid prion-detection assay
EP1876441A4 (de) Analyseverfahren für biologische probe und screening-verfahren für krankheitsmarker
EA200600539A1 (ru) Способ определения воздействия многокомпонентной смеси естественных продуктов на биологический профиль заболевания в пределах группы живых систем и разработка и контроль качества лекарственных препаратов на основе естественных продуктов
WO2004090779A3 (de) Krankheitsverlaufkontrolle
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
DE602004026439D1 (de) Lp-pla2-aktivitätstest mit hohem durchsatz
WO2005115394A3 (en) Prenyl-electrostatic switch, and methods of use
ATE421693T1 (de) Proteine in der diabetes-proteomanalyse

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties